Advanced search

Filters

Capitalization

Sector

Select all

Add a keyword

Announcement Date

Since

Until

249 Results

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results	06-04	BU
Transcript : Zuora, Inc., Q1 2025 Earnings Call, May 22, 2024	05-22
Johnson & Johnson : First Quarter 2024 2024 First-Quarter Earnings Transcript	04-18	PU
J&J to pump another $13B into its MedTech business with Shockwave deal	04-05	AQ
Johnson & Johnson : Leerink Global Biopharma Conference Transcript	03-11	PU
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results	03-11	BU
Transcript : Zuora, Inc., Q4 2024 Earnings Call, Feb 28, 2024	02-28
Joseph Wolk, CFO of J&J: End of patent for its flagship drug	01-23	MT
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results	12-11	BU
Johnson & Johnson forecasts as much as 6% sales growth in 2024	12-05	RE
Johnson & Johnson forecasts as much as 6% sales growth in 2024	12-05	RE
Health Up as Pfizer Slides -- Health Care Roundup	12-04	DJ
Tech firms, Wall Street lead job cuts in Corporate America	12-04	RE
Transcript : Zuora, Inc., Q3 2024 Earnings Call, Nov 29, 2023	11-29
Corporate America weighs business impact of new weight-loss drugs	11-13	RE
Corporate America weighs business impact of new weight-loss drugs	11-08	RE
FDA approves first Stelara biosimilar, Wezlana	11-02	AQ
Corporate America weighs business impact of new weight-loss drugs	23-10-26	RE
Medical device makers see limited hit from weight-loss drugs	23-10-20	RE
Factbox-Corporate America weighs risks of the Ozempic effect	23-10-19	RE
Corporate America weighs risks of the Ozempic effect	23-10-19	RE
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results	23-09-18	BU
Johnson & Johnson : Guidance Call Transcript - Updated	23-08-30	PU
Johnson & Johnson : Final - JNJ Guidance Webcast	23-08-30	PU
Johnson & Johnson Seeks Acquisitions	23-08-29	CI
Transcript : Zuora, Inc., Q2 2024 Earnings Call, Aug 23, 2023	23-08-23
Drugmakers go under the skin, skirting early US Medicare price negotiations	23-07-28	RE
Johnson & Johnson : JNJ-Q2 2023 Transcript Final	23-07-21	PU
J&J upbeat on 2023 as devices rebound post-COVID, shares jump	23-07-20	RE
INTERVIEW - Joseph Wolk, Johnson & Johnson: inflation law may hamper innovation	23-07-20	MT
Johnson & Johnson : FINAL - JNJ Earnings Presentation Q2 2023	23-07-20	PU
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results	23-06-06	BU
Transcript : Zuora, Inc., Q1 2024 Earnings Call, May 24, 2023	23-05-24
Factbox-Tech firms, Wall Street lead job cuts in Corporate America	23-05-02	RE
Johnson & Johnson : JNJ redline 04_18	23-04-19	PU
Johnson & Johnson : FINAL - JNJ Earnings Presentation Q1 2023	23-04-18	PU
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results	23-03-15	BU
Johnson & Johnson : JNJ USQ Transcript 2023 03 07	23-03-08	PU
Transcript : Zuora, Inc., Q4 2023 Earnings Call, Mar 01, 2023	23-03-01
Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference	23-02-06	AQ
Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference	23-02-02	BU
Johnson & Johnson : JNJ-USQ_Transcript_FINAL 2023-01-24	23-01-25	PU
Tech firms, Wall Street lead job cuts in Corporate America	23-01-25	RE
Johnson &Johnson CFO on Earnings Forecast, Costs, and Consumer Spinoff	23-01-24	MT
Johnson & Johnson : What You Need to Know About Johnson & Johnson's 2022 Fourth-Quarter and Full-Year Earnings Report	23-01-24	PU
J&J expects inflation, China COVID hit to carry into 2023	23-01-24	RE
Factbox-Tech firms leading job cuts in Corporate America	23-01-09	RE
Tech firms, Wall Street lead job cuts in Corporate America	23-01-05	RE
Factbox-Corporate America lays off thousands as recession worries mount	23-01-04	RE
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results	22-12-13	BU

No results for this search